Type I conventional dendritic cells and CD8+ T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients

Head and neck squamous cell carcinoma (HNSCC) is one of the most common tumor entities worldwide, with human papillomavirus (HPV) infection contributing to cancer development. Conventional therapies achieve only limited efficiency, especially in recurrent or metastatic HNSCC. As the immune landscape...

Full description

Bibliographic Details
Published in:Frontiers in Immunology
Main Authors: Johanna Kirchner, Ioana Plesca, Rebecca Rothe, Antonia Resag, Steffen Löck, Iva Benešová, Luise Rupp, Annett Linge, Rebekka Wehner, Mechthild Krause, Marc Schmitz
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-06-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1414298/full